Development and testing of small molecule NUDT22 inhibitors for uses in cancer
Dr T Helleday, Dr P Herr
28 February 2019
The INTEGRATA network –“Integrating chemical and biological approaches to target NAD production and signaling in cancer” – aims at providing a group of early stage researchers (ESRs) with a highly interdisciplinary and intersectoral training in drug discovery, focusing specifically on NAD production and on NAD/nucleotide signaling as targets for the development of new cancer therapeutics.
Non-coding RNA regulation of stem cells
Dr S Brown, Dr P Gokhale
Applications accepted all year round
Stem cells have the potential to make any cell type in the Human body and are powerful tools in drug discovery (Xia and Wong, 2012).